Aytu Biopharma, Inc.
AYTU
$2.19
$0.062.82%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.07M | -13.56M | 1.64M | -5.24M | -6.25M |
| Total Depreciation and Amortization | 4.75M | 5.28M | 5.55M | 5.76M | 6.22M |
| Total Amortization of Deferred Charges | 110.00K | 108.00K | 216.00K | 350.00K | 476.00K |
| Total Other Non-Cash Items | 12.07M | 12.23M | -3.79M | -2.95M | 2.24M |
| Change in Net Operating Assets | -5.23M | -6.00M | -9.14M | 2.75M | -5.05M |
| Cash from Operations | -1.37M | -1.94M | -5.53M | 673.00K | -2.37M |
| Capital Expenditure | -92.00K | -228.00K | -540.00K | -471.00K | -465.00K |
| Sale of Property, Plant, and Equipment | 151.00K | 668.00K | 668.00K | 668.00K | 517.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.00M | -3.00M | 295.00K | 250.00K | 76.00K |
| Cash from Investing | -2.94M | -2.56M | 423.00K | 447.00K | 128.00K |
| Total Debt Issued | 12.46M | 8.53M | 21.45M | 15.45M | 15.71M |
| Total Debt Repaid | -1.86M | -1.86M | -17.05M | -16.07M | -15.82M |
| Issuance of Common Stock | 14.84M | 14.84M | 3.38M | 3.38M | 3.47M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.62M | -6.07M | -4.27M | -3.01M | -975.00K |
| Cash from Financing | 16.83M | 15.44M | 3.52M | -251.00K | 2.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.52M | 10.95M | -1.59M | 869.00K | 144.00K |